Cardiovascular risk assessment in people living with HIV compared to the general population

医学 置信区间 队列 人口 人类免疫缺陷病毒(HIV) 内科学 入射(几何) 接收机工作特性 队列研究
作者
Benoît Delabays,Matthias Cavassini,Jose Damas,Hadrien Beuret,Alexandra Calmy,Barbara Hasse,Heiner C Bucher,Manuel Frischknecht,Olivier Müller,Marie Méan,Peter Vollenweider,Pedro Marques-Vidal,Julien Vaucher
出处
期刊:European Journal of Preventive Cardiology [Oxford University Press]
标识
DOI:10.1093/eurjpc/zwab201
摘要

We prospectively assessed and compared the accuracy of cardiovascular risk scores in people living with HIV (PLWH) and individuals from the general population.The Systematic Coronary Risk Evaluation Score 2 (SCORE2), the Pooled Cohort Equations (PCE), and the HIV-specific Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) score were calculated in participants free from atherosclerotic cardiovascular disease (ASCVD) between 2003 and 2009. In total, 6373 [mean age, 40.6 years (SD, 9.9)] PLWH from the Swiss HIV Cohort Study (SHCS) and 5403 [52.8 years (SD, 10.7)] individuals from the CoLaus|PsyCoLaus study were eligible for analysis. We tested discrimination and calibration, and the value of adding HIV-specific factors to scores using the net reclassification improvement (NRI). During mean follow-ups of 13.5 (SD, 4.1) in SHCS and 9.9 (SD, 2.3) years in CoLaus|PsyCoLaus study, 533 (8.4%) and 374 (6.9%) people developed an incident ASCVD, respectively. This translated into age-adjusted incidence rates of 12.9 and 7.5 per 1000 person-year, respectively. In SHCS, SCORE2, PCE, and D:A:D presented comparable discriminative capacities [area under the receiver operating characteristic curve of 0.745 (95% confidence interval, CI, 0.723-0.767), 0.757 (95% CI, 0.736-0.777), and 0.763 (95% CI, 0.743-0.783)]. Adding HIV-specific variables (CD4 nadir and abacavir exposure) to SCORE2 and PCE resulted in an NRI of -0.1% (95% CI, -1.24 to 1, P = 0.83) and of 2.7% (95% CI, 0.3-5.1, P = 0.03), respectively.PLWH present a two-fold higher rate of incident ASCVD compared to individuals from the general population. SCORE2 and PCE, which are clinically easier to use (reduced set of variables without adding HIV-specific factors), are valid to predict ASCVD in PLWH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
量子星尘发布了新的文献求助10
刚刚
刚刚
1秒前
1秒前
JamesPei应助科研通管家采纳,获得10
1秒前
1秒前
科研通AI5应助科研通管家采纳,获得10
1秒前
wanci应助科研通管家采纳,获得10
1秒前
隐形曼青应助科研通管家采纳,获得10
1秒前
Akim应助科研通管家采纳,获得10
1秒前
jyy应助科研通管家采纳,获得10
1秒前
小二郎应助科研通管家采纳,获得10
1秒前
思源应助科研通管家采纳,获得10
1秒前
1秒前
2秒前
YPP完成签到,获得积分10
2秒前
王汉韬完成签到,获得积分20
3秒前
奥一奥完成签到,获得积分10
4秒前
欣喜沛芹发布了新的文献求助10
4秒前
纾缓发布了新的文献求助10
4秒前
WW完成签到,获得积分10
4秒前
zlttt完成签到,获得积分20
5秒前
852应助momo采纳,获得10
6秒前
此间少年发布了新的文献求助10
6秒前
王汉韬发布了新的文献求助10
6秒前
哈哈完成签到 ,获得积分10
7秒前
英俊的铭应助xn201120采纳,获得10
7秒前
闾丘惜萱完成签到,获得积分10
7秒前
baonali发布了新的文献求助10
9秒前
yyyhhh完成签到,获得积分10
11秒前
ZH完成签到 ,获得积分10
15秒前
15秒前
15秒前
ll完成签到,获得积分10
16秒前
纾缓完成签到,获得积分10
18秒前
潘善若发布了新的文献求助10
18秒前
23秒前
Willy完成签到,获得积分10
24秒前
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136